Sara J. Newmann

Learn More
W orldwide, an estimated 493,243, cases of invasive cervical cancer (ICC) occur each year and 273,505 women die of the disease. 1 There is a global disparity in the incidence of cervical cancer, with the burden of cases occurring in less developed countries (83%), where effective cervical cancer screening and treatment services have often been difficult to(More)
OBJECTIVE To determine whether integrating family planning services into HIV care is associated with increased use of more effective contraceptive methods (sterilization, intrauterine device, implant, injectable or oral contraceptives). DESIGN Cluster-randomized trial. SETTING Eighteen public HIV clinics in Nyanza Province, Kenya. PARTICIPANTS Women(More)
Despite increasing efforts to address the reproductive health needs of people living with HIV, a high unmet need for contraception exists among HIV+ women in sub-Saharan Africa. This study explores the fertility intentions and family planning (FP) preferences of Kenyan women accessing HIV treatment. We conducted 30 semistructured interviews and(More)
Objective. To inform an intervention integrating family planning into HIV care, family planning (FP) knowledge, attitudes and practices, and perspectives on integrating FP into HIV care were assessed among healthcare providers in Nyanza Province, Kenya. Methods. Thirty-one mixed-method, structured interviews were conducted among a purposive sample of(More)
This study explored barriers to and facilitators of using family planning services among HIV-positive men in Nyanza Province, Kenya. From May to June 2010, in-depth interviews were conducted with 30 men receiving care at 15 HIV clinics. The key barriers to the use of family planning included concerns about side effects of contraceptives, lack of knowledge(More)
OBJECTIVES To determine if integration of family planning (FP) and HIV services led to increased use of more effective contraception (i.e. hormonal and permanent methods, and intrauterine devices) and decreased pregnancy rates. DESIGN Cohort analysis following cluster randomized trial, when the Kenya Ministry of Health led integration of the remaining(More)
SUMMARY Background—Given recent concerns of efavirenz reducing the efficacy of contraceptive implants, we sought to determine if pregnancy rates differ among HIV-positive women using various contraceptive methods and efavirenz-or nevirapine-based antiretroviral therapy (ART) regimens.
  • 1